--- title: Buy Xarelto (Rivaroxaban) 10/15/20mg Pills Online description: Xarelto (Rivaroxaban) 10mg, 15mg, 20mg pills reduce stroke risk in atrial fibrillation and treat blood clots. Order from our verified secure pharmacy for reliable quality. type: product language: en url: https://liabilis.com/order-xarelto-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 55.99 price_max: 167.99 currency: USD offers: - name: 10mg x 56 pills price: 55.99 - name: 10mg x 28 pills price: 55.99 - name: 15mg x 28 pills price: 97.99 - name: 15mg x 56 pills price: 139.99 - name: 20mg x 28 pills price: 111.99 - name: 20mg x 56 pills price: 167.99 --- # Buy Xarelto (Rivaroxaban) 10/15/20mg Pills Online Xarelto, containing Rivaroxaban, is an oral anticoagulant developed by Bayer. It helps prevent stroke and systemic embolism in adults with nonvalvular atrial fibrillation and treats deep vein thrombosis and pulmonary embolism. This factor Xa inhibitor is for patients at risk of clotting. Our online pharmacy offers Xarelto in 10mg, 15mg, and 20mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **10mg** | 56 pills | **$55.99** | $1.00 | In Stock | | **10mg** | 28 pills | **$55.99** | $2.00 | In Stock | | **15mg** | 28 pills | **$97.99** | $3.50 | In Stock | | **15mg** | 56 pills | **$139.99** | $2.50 | In Stock | | **20mg** | 28 pills | **$111.99** | $4.00 | In Stock | | **20mg** | 56 pills | **$167.99** | $3.00 | In Stock | [Buy Now](https://liabilis.com/order-xarelto-online-en.html) ## Introduction Xarelto (Rivaroxaban) is an oral anticoagulant prescribed to prevent and treat thromboembolic disorders. It is available as a pill in strengths of 10 mg, 15 mg, and 20 mg and belongs to the class of direct Factor Xa inhibitors. Clinicians use Xarelto to reduce the risk of stroke in atrial fibrillation, to manage deep-vein thrombosis (DVT) and pulmonary embolism (PE), and to provide prophylaxis after orthopedic surgery. Secondary uses include treatment of acute coronary syndrome in selected patients, though these are not primary regulatory indications. --- ## Quick Reference Facts **Active Ingredient** : Rivaroxaban **Form** : pill 10 mg | 15 mg | 20 mg **Primary and Off-Label Uses** : • Stroke prevention in non-valvular atrial fibrillation : • Treatment of DVT and PE : • Post-operative thromboprophylaxis after total hip or knee replacement : • Off-label: use in certain acute coronary syndrome protocols (physician-supervised) --- ## What is Xarelto? Xarelto is a brand-name oral anticoagulant marketed by Bayer Pharma. It contains the active compound rivaroxaban, a synthetic small-molecule inhibitor of coagulation Factor Xa. Approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), Xarelto is indicated for several thrombotic conditions. While it is a proprietary product, generic formulations containing rivaroxaban are available and may be obtained at lower cost. The brand benefits from extensive clinical trial data that supported its registration across multiple jurisdictions. --- ## How Xarelto Works Rivaroxaban directly blocks Factor Xa, an essential enzyme that converts prothrombin to thrombin in the coagulation cascade. By inhibiting this step, the drug reduces thrombin generation and consequently prevents fibrin clot formation. The inhibition is reversible and does not require antithrombin III as a cofactor, distinguishing it from older agents such as warfarin. After oral administration, rivaroxaban reaches peak plasma concentrations within 2-4 hours (earlier with the 10 mg dose taken with food). It exhibits a half-life of approximately 5-9 hours in younger adults, extending to 11-13 hours in the elderly. Metabolism occurs primarily via CYP3A4 and CYP2J2, with renal excretion accounting for about one-third of the eliminated dose; the remainder is eliminated unchanged in the feces. These pharmacokinetic properties allow once-daily dosing for most indications. --- ## Conditions Treated with Xarelto - **Stroke Prevention in Non-Valvular Atrial Fibrillation** Patients with atrial fibrillation are at increased risk of embolic stroke. By reducing thrombin generation, Xarelto lowers this risk without the need for routine INR monitoring required by warfarin. - **Treatment of Deep-Vein Thrombosis (DVT) and Pulmonary Embolism (PE)** Acute clot burden in the leg veins or pulmonary arteries can be rapidly reduced. Xarelto’s predictable anticoagulant effect enables fixed-dose therapy without bridging heparin in many cases. - **Extended Treatment after Initial DVT/PE Therapy** After a 3-month standard course, continued low-dose rivaroxaban (10 mg daily) diminishes recurrence rates while maintaining a favorable safety profile. - **Thromboprophylaxis after Hip or Knee Replacement Surgery** Surgical trauma triggers coagulation activation. A once-daily postoperative regimen of Xarelto for 12-35 days (depending on joint) effectively prevents postoperative DVT/PE. - **Prevention of Recurrent Venous Thromboembolism in Cancer-Associated Thrombosis (selected patients)** In malignancy-related clotting, Xarelto offers an oral alternative to injectable low-molecular-weight heparin, though clinicians must assess bleeding risk carefully. --- ## Is Xarelto the Right Medication for You? Xarelto is appropriate for adults with confirmed atrial fibrillation, acute or chronic venous thromboembolism, or those undergoing major orthopedic surgery who require anticoagulation and have acceptable renal function (creatinine clearance ≥ 30 mL/min for most doses). It is especially useful for patients who prefer oral therapy over injections and who desire predictable anticoagulation without frequent laboratory monitoring. Contraindications include active pathological bleeding, severe hypersensitivity to rivaroxaban, and pregnancy (category C). Caution is advised in patients with hepatic impairment (Child-Pugh B), uncontrolled hypertension, or a history of intracranial hemorrhage. Individuals with creatinine clearance < 15 mL/min should avoid Xarelto, as accumulation may increase bleeding risk. Physicians often select Xarelto when rapid onset, fixed dosing, and a modest drug-interaction profile are priorities. Patients with high bleeding susceptibility, severe kidney disease, or those requiring rapid reversal may be better served by alternative agents such as warfarin or injectable heparins. --- ## Buying Xarelto from [our online pharmacy](https://liabilis.com/order-xarelto-online-en.html) ### Why Choose Our Service? Our platform provides a discreet, reliable way to obtain Xarelto when traditional pharmacies face stock shortages or pricing barriers. We focus on delivering the medication swiftly while safeguarding your privacy. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every batch is sourced from manufacturers that meet stringent regulatory standards, and our pharmacy service works exclusively with verified overseas suppliers who adhere to recognized quality frameworks. ### Pricing & Access Because we source directly from authorized distributors, the cost of Xarelto through [our online pharmacy](https://liabilis.com/order-xarelto-online-en.html) is close to manufacturer pricing, often lower than retail rates in many countries. This approach helps patients who might otherwise forgo treatment due to expense. ### Discreet Delivery Orders are packaged in unmarked, tamper-evident envelopes and dispatched via express delivery typically within 7 days, or by standard airmail in approximately 3 weeks. Our delivery system respects confidentiality and complies with international shipping regulations. Through our pharmacy service, you gain affordable access to a clinically proven anticoagulant without compromising safety or privacy. --- ## Use: Dosing, Missed Dose, Overdose - **Standard Dosing** - Atrial fibrillation: 20 mg once daily with the evening meal (15 mg once daily if creatinine clearance 15-49 mL/min). - Treatment of DVT/PE: 15 mg twice daily with food for the first 21 days, then 20 mg once daily with food. - Post-operative thromboprophylaxis: 10 mg once daily, initiated 6-10 hours after surgery, continued for 12-35 days depending on procedure. - **Missed Dose** If you realize a dose was missed, take it as soon as you remember **provided** it is more than 12 hours since the scheduled time. If the interval is longer, skip the missed dose and resume the regular schedule. Do not double-dose. - **Overdose** Suspected overdose may present with unusual bruising, nosebleeds, hematuria, or melena. Seek immediate medical attention; activated charcoal is not effective, but specific reversal agents (andexanet alfa) are available in hospital settings. - **Practical Precautions** - Take Xarelto with food to improve absorption, especially for the 15 mg and 20 mg strengths. - Avoid excessive alcohol, which can amplify bleeding risk. - Do not operate heavy machinery or drive if you feel light-headed or experience bleeding. --- ## Safety Information ### ⚠️ Who Should Not Take Xarelto - Active major bleeding (e.g., intracranial, gastrointestinal). - Severe hypersensitivity to rivaroxaban or any excipients. - Pregnant women (unless benefits outweigh risks, under specialist guidance). - Patients with creatinine clearance < 15 mL/min. ### Common Side Effects - Minor bruising or prolonged bleeding from cuts. - Nasal congestion or mild nosebleeds. - Gastrointestinal discomfort such as dyspepsia. These effects are typically self-limiting; if they persist, contact your healthcare provider. ### Serious Side Effects (Seek Immediate Medical Help) - Intracranial hemorrhage (headache, weakness, loss of consciousness). - Massive gastrointestinal bleeding (black or tarry stools, vomiting blood). - Severe allergic reaction (rash, swelling, difficulty breathing). Prompt emergency care is essential for these events. ### Drug & Food Interactions - **Strong CYP3A4 inhibitors** (e.g., ketoconazole, ritonavir) increase rivaroxaban plasma levels → heightened bleeding risk. - **Strong CYP3A4 inducers** (e.g., rifampin, carbamazepine) reduce efficacy → possible clot recurrence. - **Antiplatelet agents** (aspirin, clopidogrel) and NSAIDs add to bleeding risk; concurrent use should be evaluated by a clinician. - **Anticoagulants** (warfarin, heparin) may cause over-anticoagulation if combined. - **Food**: High-fat meals improve absorption of higher doses; consistent intake with meals is recommended. --- ## Off-Label and Investigational Uses of Xarelto - **Acute Coronary Syndrome (ACS)**: Some cardiology trials have explored low-dose rivaroxaban (2.5 mg twice daily) added to antiplatelet therapy to reduce cardiovascular events. This regimen is not FDA-approved for ACS and should only be used under specialist supervision. - **Cancer-Associated Thrombosis**: Although guidelines primarily endorse low-molecular-weight heparin, observational studies suggest rivaroxaban may be an oral alternative for selected oncology patients. Formal approval is pending further randomized data. - **Peripheral Artery Disease (PAD) Prevention**: Investigational protocols evaluate rivaroxaban combined with aspirin to lower the risk of limb ischemia. Evidence remains limited, and usage outside clinical trials is discouraged. These applications are investigational; clinicians must weigh the limited evidence against potential risks and obtain informed consent. --- ## Storage & Handling - Store tablets at 20-25 °C (68-77 °F) in a dry place, away from moisture and direct sunlight. - Keep the container tightly closed to protect from humidity. - Do not refrigerate or freeze. - Dispose of unused tablets according to local hazardous-waste regulations or return them to a pharmacy for safe disposal. --- ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I travel internationally with Xarelto?** Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be prepared for customs inspections. - **Will taking Xarelto affect my ability to fly?** Air travel does not impact rivaroxaban’s efficacy. However, stay hydrated and avoid excessive alcohol, which could increase bleeding risk. - **Is it safe to take Xarelto with over-the-counter supplements?** Certain supplements, such as high-dose omega-3 fatty acids or vitamin K, may affect clotting. Discuss any supplement use with your pharmacist. **Product & Formulation Details** - **What do Xarelto tablets look like?** Xarelto tablets are round, film-coated, and color-coded: 10 mg (white), 15 mg (light orange), and 20 mg (dark orange). - **Can the tablets be split or crushed?** The 20 mg tablet is scored and can be split, but crushing any rivaroxaban tablet may alter absorption and is discouraged unless a healthcare professional advises otherwise. **Regulatory & Safety Nuances** - **Will Xarelto show up on a standard drug test for athletes?** Routine employment or sports drug screens do not test for anticoagulants; however, therapeutic-use exemptions may be required for competitive athletics. - **Are there special import rules for Xarelto in my country?** Import regulations vary; many jurisdictions permit personal import of a 30-day supply for personal use, provided a valid prescription is included. Verify local customs guidelines before ordering. **Scientific & Clinical Curiosity** - **What was the pivotal trial that led to Xarel0 approval?** The RECORD and EINSTEIN series of phase III trials demonstrated non-inferiority to warfarin for VTE treatment and superiority for postoperative thromboprophylaxis, forming the basis for regulatory approval. - **How does Xarelto compare to dabigatran, another oral anticoagulant?** Both are direct oral anticoagulants but target different clotting factors: rivaroxaban inhibits Factor Xa, while dabigatran inhibits thrombin (Factor IIa). Their dosing schedules, renal clearance, and interaction profiles differ, influencing clinician choice. --- ## Glossary **Factor Xa** : An enzyme in the coagulation cascade that converts prothrombin to thrombin; inhibition reduces clot formation. **Bioavailability** : The proportion of a drug that reaches systemic circulation unchanged after oral administration. **Creatinine Clearance** : A measure of kidney function used to estimate how well the kidneys filter waste; important for dosing anticoagulants. **Therapeutic Window** : The dosage range in which a drug is effective without causing unacceptable side effects. **Reversal Agent** : A medication (e.g., andexanet alfa for rivaroxaban) that counteracts the anticoagulant effect in emergency bleeding situations. --- ## Disclaimer The information presented about Xarelto is intended for general educational purposes and does not replace personalized medical advice. Treatment decisions, including those involving off-label applications, should be made under the guidance of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://liabilis.com/order-xarelto-online-en.html) provides access to Xarelto for individuals who may encounter limited availability, restrictive insurance formularies, or who seek cost-effective alternatives. Always discuss any medication changes with your physician before initiating, adjusting, or discontinuing therapy.